| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1059757
[patent_doc_number] => 06852847
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-08
[patent_title] => 'Canine and feline B7-2 nucleic acid molecules and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 09/646561
[patent_app_country] => US
[patent_app_date] => 1999-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29725
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852847.pdf
[firstpage_image] =>[orig_patent_app_number] => 09646561
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/646561 | Canine and feline B7-2 nucleic acid molecules and uses thereof | Mar 18, 1999 | Issued |
| 09/254460 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES | Mar 8, 1999 | Abandoned |
Array
(
[id] => 1533771
[patent_doc_number] => 06410708
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Nucleic acids encoding A-33 related antigen polypeptides'
[patent_app_type] => B1
[patent_app_number] => 09/254465
[patent_app_country] => US
[patent_app_date] => 1999-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 28
[patent_no_of_words] => 39525
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410708.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254465
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254465 | Nucleic acids encoding A-33 related antigen polypeptides | Mar 4, 1999 | Issued |
| 09/254368 | MONOCLONAL ANTIBODIES SPECIFIC FOR PROSTATE SPECIFIC ANTIGEN AND METHODS OF DETECTING PROSTATE SPECIFIC ANTIGEN | Mar 3, 1999 | Abandoned |
Array
(
[id] => 4324443
[patent_doc_number] => 06312700
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Method for enhancing an antigen specific immune response with OX-40L'
[patent_app_type] => 1
[patent_app_number] => 9/255363
[patent_app_country] => US
[patent_app_date] => 1999-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 15438
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312700.pdf
[firstpage_image] =>[orig_patent_app_number] => 255363
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/255363 | Method for enhancing an antigen specific immune response with OX-40L | Feb 22, 1999 | Issued |
Array
(
[id] => 6899987
[patent_doc_number] => 20010009663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-26
[patent_title] => 'NON-LETHAL METHODS FOR CONDITIONING A RECIPIENT FOR BONE MARROW TRANSPLANTATION'
[patent_app_type] => new
[patent_app_number] => 09/245038
[patent_app_country] => US
[patent_app_date] => 1999-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19833
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20010009663.pdf
[firstpage_image] =>[orig_patent_app_number] => 09245038
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/245038 | NON-LETHAL METHODS FOR CONDITIONING A RECIPIENT FOR BONE MARROW TRANSPLANTATION | Feb 4, 1999 | Abandoned |
| 09/240253 | METHOD OF TREATING DEMYELINATING INFLAMMATORY DISEASE USING CCR1 ANTAGONISTS | Jan 28, 1999 | Abandoned |
| 09/239283 | METHODS FOR INHIBITING GRAFT REJECTION USING AN ANTAGONIST OF CCR1 FUNCTION | Jan 28, 1999 | Abandoned |
| 09/202346 | HEXAMERIC FUSION PROTEINS AND USES THEREFOR | Jan 12, 1999 | Abandoned |
| 09/201931 | MEMBRANE-BOUND CYTOKINE COMPOSITIONS AND METHODS OF MODULATING AN IMMUNE RESPONSE USING SAME | Nov 30, 1998 | Abandoned |
| 09/193548 | ANTI-ICAM-R ANTIBODY-INDUCED APOPTOSIS | Nov 16, 1998 | Abandoned |
Array
(
[id] => 6876484
[patent_doc_number] => 20010006637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-05
[patent_title] => 'RHEUMATOID ARTHRITIS REMEDY CONTAINING ANTI-IL-8 ANTIBODY AS ACTIVE INGREDIENT'
[patent_app_type] => new-utility
[patent_app_number] => 09/171656
[patent_app_country] => US
[patent_app_date] => 1998-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8191
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20010006637.pdf
[firstpage_image] =>[orig_patent_app_number] => 09171656
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/171656 | RHEUMATOID ARTHRITIS REMEDY CONTAINING ANTI-IL-8 ANTIBODY AS ACTIVE INGREDIENT | Oct 18, 1998 | Abandoned |
Array
(
[id] => 1413429
[patent_doc_number] => 06514497
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-04
[patent_title] => 'Inhibition of LERK-2-mediated cell adhesion'
[patent_app_type] => B1
[patent_app_number] => 09/164621
[patent_app_country] => US
[patent_app_date] => 1998-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12413
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/514/06514497.pdf
[firstpage_image] =>[orig_patent_app_number] => 09164621
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/164621 | Inhibition of LERK-2-mediated cell adhesion | Sep 30, 1998 | Issued |
| 09/137273 | HUMAN ANGIOPOIETIN | Aug 19, 1998 | Abandoned |
Array
(
[id] => 1387306
[patent_doc_number] => 06540992
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Methods for using elk-L to enhance neuronal survival'
[patent_app_type] => B1
[patent_app_number] => 09/039642
[patent_app_country] => US
[patent_app_date] => 1998-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15559
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/540/06540992.pdf
[firstpage_image] =>[orig_patent_app_number] => 09039642
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/039642 | Methods for using elk-L to enhance neuronal survival | Mar 15, 1998 | Issued |
| 08/930802 | IMMUNOSUPPRESSANT | Oct 6, 1997 | Abandoned |
Array
(
[id] => 1565771
[patent_doc_number] => 06339148
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-15
[patent_title] => 'Isolated nucleic acid encoding an integrin -subunit'
[patent_app_type] => B1
[patent_app_number] => 08/938085
[patent_app_country] => US
[patent_app_date] => 1997-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18096
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/339/06339148.pdf
[firstpage_image] =>[orig_patent_app_number] => 08938085
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/938085 | Isolated nucleic acid encoding an integrin -subunit | Sep 25, 1997 | Issued |
Array
(
[id] => 1413696
[patent_doc_number] => 06528625
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Anti-CCR5 antibodies and kits comprising same'
[patent_app_type] => B1
[patent_app_number] => 08/893911
[patent_app_country] => US
[patent_app_date] => 1997-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 32
[patent_no_of_words] => 24116
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528625.pdf
[firstpage_image] =>[orig_patent_app_number] => 08893911
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/893911 | Anti-CCR5 antibodies and kits comprising same | Jul 10, 1997 | Issued |
Array
(
[id] => 1387413
[patent_doc_number] => 06540999
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Immunomodulatory methods using Lewisx oligosacchardies'
[patent_app_type] => B1
[patent_app_number] => 08/792023
[patent_app_country] => US
[patent_app_date] => 1997-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 29
[patent_no_of_words] => 16740
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/540/06540999.pdf
[firstpage_image] =>[orig_patent_app_number] => 08792023
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/792023 | Immunomodulatory methods using Lewisx oligosacchardies | Jan 30, 1997 | Issued |
Array
(
[id] => 1361658
[patent_doc_number] => 06573362
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-03
[patent_title] => 'Cythohesin-PH peptides that affect the ability of integrins to adhere'
[patent_app_type] => B1
[patent_app_number] => 08/708573
[patent_app_country] => US
[patent_app_date] => 1996-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 10724
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/573/06573362.pdf
[firstpage_image] =>[orig_patent_app_number] => 08708573
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/708573 | Cythohesin-PH peptides that affect the ability of integrins to adhere | Sep 4, 1996 | Issued |
